- Optic Disc Edema Responding to Localized Anti-vascular Endothelial Growth Factor Treatment in a Patient with POEMS Syndrome
-
Song HB, Yu HG
- KMID: 2363813
- Korean J Ophthalmol.
- 2015 Oct;29(5):357-358.
- doi: 10.3341/kjo.2015.29.5.357
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Aflibercept Treatment for Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy Refractory to Anti-vascular Endothelial Growth Factor
-
Moon DR, Lee DK, Kim SH, You YS, Kwon OW
- KMID: 2363766
- Korean J Ophthalmol.
- 2015 Aug;29(4):226-232.
- doi: 10.3341/kjo.2015.29.4.226
PURPOSE: To report the results of switching treatment to vascular endothelial growth factor (VEGF) Trap-Eye (aflibercept) in neovascular age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy (PCV) refractory to anti-VEGF... -
- CITED
-
- Close
- SHARE
-
- Close
- Influence of vascular endothelial growth factor inhibition on simple renal cysts in patients receiving bevacizumab-based chemotherapy
-
Grenader T, Shavit L
- KMID: 2359870
- Korean J Urol.
- 2015 Dec;56(12):791-795.
- doi: 10.4111/kju.2015.56.12.791
PURPOSE: Although angiogenesis has been implicated in the promotion of renal cyst growth in autosomal dominant polycystic kidney disease, no studies have investigated the role of angiogenesis in the growth... -
- CITED
-
- Close
- SHARE
-
- Close
- Changes in Fundus Autofluorescence after Anti-vascular Endothelial Growth Factor According to the Type of Choroidal Neovascularization in Age-related Macular Degeneration
-
Lee JY, Chung H, Kim HC
- KMID: 2363886
- Korean J Ophthalmol.
- 2016 Feb;30(1):17-24.
- doi: 10.3341/kjo.2016.30.1.17
PURPOSE: To describe the changes of fundus autofluorescence (FAF) in patients with age-related macular degeneration before and after intravitreal injection of anti-vascular endothelial growth factor according to the type of... -
- CITED
-
- Close
- SHARE
-
- Close
- Intravitreal Anti-vascular Endothelial Growth Factor for Newly Diagnosed Symptomatic Polypoidal Choroidal Vasculopathy with Extrafoveal Polyps
-
Kim JH, Lee DW, Choi SC, Kim JW, Lee TG, Kim CG, Cho HJ
- KMID: 2363848
- Korean J Ophthalmol.
- 2015 Dec;29(6):404-410.
- doi: 10.3341/kjo.2015.29.6.404
PURPOSE: To evaluate the 12-month outcome of anti-vascular endothelial growth factor (VEGF) treatment for extrafoveal polypoidal choroidal vasculopathy (PCV). METHODS: This retrospective observational study included 32 eyes of 32 patients newly... -
- CITED
-
- Close
- SHARE
-
- Close
- Intravitreal Anti-vascular Endothelial Growth Factor for Treating Polypoidal Choroidal Vasculopathy with Grape-like Polyp Clusters
-
Chang YS, Kim JH, Kim JW, Lee TG, Kim CG
- KMID: 2373987
- Korean J Ophthalmol.
- 2016 Aug;30(4):272-279.
- doi: 10.3341/kjo.2016.30.4.272
PURPOSE: To evaluate 12-month outcomes of anti-vascular endothelial growth factor (VEGF) therapy for polypoidal choroidal vasculopathy (PCV) with grape-like polyp clusters. METHODS: This retrospective observational study included 23 eyes of 23... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Outcomes of Eyes with Submacular Hemorrhage Secondary to Age-related Macular Degeneration Treated with Anti-vascular Endothelial Growth Factor
-
Kim KH, Kim JH, Chang YS, Lee TG, Kim JW, Lew YJ
- KMID: 2363805
- Korean J Ophthalmol.
- 2015 Oct;29(5):315-324.
- doi: 10.3341/kjo.2015.29.5.315
PURPOSE: To evaluate the long-term outcomes of intravitreal anti-vascular endothelial growth factor (VEGF) monotherapy for patients diagnosed with submacular hemorrhage secondary to exudative age-related macular degeneration. METHODS: This retrospective, observational study... -
- CITED
-
- Close
- SHARE
-
- Close
- Subconjunctival Bevacizumab as an Adjunct to Trabeculectomy in Eyes with Refractory Glaucoma: A Case Series
-
Choi JY, Choi J, Kim YD
- KMID: 1098794
- Korean J Ophthalmol.
- 2010 Feb;24(1):47-52.
- doi: 10.3341/kjo.2010.24.1.47
This prospective observational case series study included 6 eyes of 6 consecutive glaucomatous patients. Each patient underwent trabeculectomy with mitomycin C, and received a 1.25 mg of subconjunctival bevacizumab injection... -
- CITED
-
- Close
- SHARE
-
- Close
- A serum-stable branched dimeric anti-VEGF peptide blocks tumor growth via anti-angiogenic activity
-
Kim JW, Kim TD, Hong BS, Kim OY, Yoon WH, Chae CB, Gho YS
- KMID: 1104211
- Exp Mol Med.
- 2010 Jul;42(7):514-523.
- doi: 10.3858/emm.2010.42.7.052
Angiogenesis is critical and indispensable for tumor progression. Since VEGF is known to play a central role in angiogenesis, the disruption of VEGF-VEGF receptor system is a promising target for... -
- CITED
-
- Close
- SHARE
-
- Close
- Anti-VEGF-refractory Exudative Age-related Macular Degeneration: Differential Response According to Features on Optical Coherence Tomography
-
Shin JY, Woo SJ, Ahn J, Park KH
- KMID: 1792078
- Korean J Ophthalmol.
- 2013 Dec;27(6):425-432.
- doi: 10.3341/kjo.2013.27.6.425
PURPOSE: To describe optical coherence tomography (OCT) characteristics of neovascular age-related macular degeneration (AMD) patients refractory to intravitreal anti-vascular endothelial growth factor (VEGF) injections (ranibizumab, bevacizumab) and their responses to... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Injection of Intravitreal Drugs with Standard Care in Macular Edema Secondary to Branch Retinal Vein Occlusion
-
Lee K, Jung H, Sohn J
- KMID: 1792090
- Korean J Ophthalmol.
- 2014 Feb;28(1):19-25.
- doi: 10.3341/kjo.2014.28.1.19
PURPOSE: To compare the long-term efficacy and safety of intravitreal triamcinolon with or without rescue laser therapy (intravitreal triamcinolone injection [IVTA] group), bevacizumab with or without rescue laser treatment (intravitreal... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Intravitreal Bevacizumab in Patients with Acute Central Serous Chorioretinopathy
-
Lim JW, Ryu SJ, Shin MC
- KMID: 945985
- Korean J Ophthalmol.
- 2010 Jun;24(3):155-158.
- doi: 10.3341/kjo.2010.24.3.155
PURPOSE: To evaluate the effect of intravitreal bevacizumab injection (IVBI) in acute central serous chorioretinopathy (CSC) patients. METHODS: Patients with acute CSC received IVBI (1.25 mg/0.05 mL) or observation by... -
- CITED
-
- Close
- SHARE
-
- Close
